Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

CONJUPRI TABLETS 2.5MG

Approval Number

SIN17154P

Drug Name

CONJUPRI TABLETS 2.5MG

Product Name

CONJUPRI TABLETS 2.5MG

Approval Date

December 26, 2024

Registrant

LOTUS INTERNATIONAL PTE. LTD.

Regulatory Information

Registrant

LOTUS INTERNATIONAL PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

C08CA17

Manufacturer Information

Pharmaceutical Manufacturer

LOTUS INTERNATIONAL PTE. LTD.

Manufacturers

CSPC Ouyi Pharmaceutical Co., Ltd.

Active Ingredients

Ingredient Name

Levamlodipine maleate eqv. levamlodipine

Strength

2.50 mg

Drug MonographLevamlodipine

Documents

Package Inserts

Conjupri Tablets PI.pdf

Approved: December 26, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy